Emy Smith
Acute Care · Dallas, TXNPI 1508104886
Payments from drug & device makers
Across 81 payments — averaging $93.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$6K
- Intuitive Surgical$417
- AstraZeneca$394
- La Jolla Pharmaceutical Company$144
- Olympus America Inc.$110
- Arthrex$106
- plus $705 from 20 others
What the payments were for
- Consulting fees$4,13854%
- Travel & lodging$83711%
- Food & beverage$2,61434%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 28 | $5,727 |
| Intuitive Surgical | 8 | $417 |
| AstraZeneca | 5 | $394 |
| La Jolla Pharmaceutical Company | 7 | $144 |
| Olympus America Inc. | 6 | $110 |
| Arthrex | 1 | $106 |
| Shionogi Inc | 1 | $94 |
| Kerecis Limited | 1 | $82 |
| Johnson & Johnson | 3 | $67 |
| Integra Lifesciences Corporation | 2 | $54 |
| Medtronic | 2 | $48 |
| Novocure Inc. | 1 | $46 |
| Boston Scientific | 2 | $36 |
| Potrero Medical, Inc. | 1 | $34 |
| Nestle Healthcare Nutrition Inc. | 2 | $32 |
| Chiesi USA, Inc. | 1 | $24 |
| Cook Medical LLC | 1 | $24 |
| Merck | 1 | $24 |
| Cvrx, Inc. | 1 | $23 |
| Haemonetics Corporation | 1 | $20 |
| Davol Inc. | 1 | $18 |
| Molnlycke Health Care US, LLC | 1 | $18 |
| Corcym Inc | 1 | $17 |
| Micro-tech Endoscopy USA, Inc. | 1 | $16 |
| Abiomed | 1 | $15 |
| Pinnacle Biologics, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,604 in reported general payments places this provider in the 95th percentile of 2,323 acute care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LoperamideLoperamide Hcl | 12 | $729 |
| Gabapentin | 21 | $211 |
Paid to pharmacies, not to this prescriber.
Other acute care in Dallas
- Jennifer PilotteDallas$232K
- Amanda BradleyDallas$85K
- Martha LibertyDallas$28K
- Rachael SchneiderDallas$20K
- Peter TriporoDallas$15K
- Mario PadillaDallas$13K
- Toni SmithDallas$10K
- Christie MorrisonSan Antonio$225K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.